MBX Biosciences
$29.85
8
+$2.93+10.88% Tuesday 20:00
Statistics
Day High
30.29
Day Low
27.78
52W High
44.89
52W Low
4.81
Volume
517,900
Avg. Volume
636,885
Mkt Cap
1.34B
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
18MayExpected
Expected EPS
-0.572062
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-64.91MNet Income
Analyst Ratings
$53.20Average Price Target
The highest estimate is 88.00.
From 6 ratings within the last 6 months. This is not an investment recommendation.
From 6 ratings within the last 6 months. This is not an investment recommendation.
Buy 83%
Hold 0%
Sell 17%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow MBX. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
MBX Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of precision peptide therapies for the treatment of endocrine and metabolic disorders. Its lead product candidate is MBX 2109, a parathyroid hormone peptide prodrug, which is in Phase 2 clinical trial designed as a potential long-acting hormone replacement therapy for the treatment of chronic hypoparathyroidism. The company is also developing MBX 1416, a long-acting glucagon-like peptide-1 (GLP-1) receptor antagonist that is in Phase 1 clinical trial designed as a potential therapy for post-bariatric hypoglycemia, a chronic complication of bariatric surgery. In addition, it is developing MBX 4291, a lead obesity product candidate, which is in investigational new drug-enabling studies designed as a long-acting and highly potent GLP-1 and glucose-dependent insulinotropic polypeptide receptor co-agonist prodrug for treating obesity and co-morbidities. The company was founded in 2018 and is based in Carmel, Indiana.
Show more...
CEO
Mr. Peter Kent Hawryluk MBA
Employees
43
Country
US
ISIN
US55287L1017
Listings
0 Comments
Share your thoughts
FAQ
What is MBX Biosciences stock price today?▼
The current price of MBX is $29.85 USD — it has increased by +10.88% in the past 24 hours. Watch MBX Biosciences stock price performance more closely on the chart.
What is MBX Biosciences stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange MBX Biosciences stocks are traded under the ticker MBX.
Is MBX Biosciences stock price growing?▼
MBX stock has risen by +3.07% compared to the previous week, the month change is a -8.29% fall, over the last year MBX Biosciences has showed a +335.13% increase.
What is MBX Biosciences market cap?▼
Today MBX Biosciences has the market capitalization of 1.34B
When is the next MBX Biosciences earnings date?▼
MBX Biosciences is going to release the next earnings report on May 18, 2026.
What were MBX Biosciences earnings last quarter?▼
MBX earnings for the last quarter are -0.49 USD per share, whereas the estimation was -0.63 USD resulting in a +22.17% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is MBX Biosciences revenue for the last year?▼
MBX Biosciences revenue for the last year amounts to 0 USD.
What is MBX Biosciences net income for the last year?▼
MBX net income for the last year is -64.91M USD.
How many employees does MBX Biosciences have?▼
As of April 01, 2026, the company has 43 employees.
In which sector is MBX Biosciences located?▼
MBX Biosciences operates in the Health Care sector.
When did MBX Biosciences complete a stock split?▼
MBX Biosciences has not had any recent stock splits.
Where is MBX Biosciences headquartered?▼
MBX Biosciences is headquartered in Carmel, US.